80 likes | 89 Vues
Herpes Zoster (Shingles) Market Size is estimated to reach $275.9 million by 2027 and is poised to grow at a CAGR of 3.5% over the forecast period of 2022-2027. The varicella-zoster virus, which is a common viral infection of the nerves, causes herpes zoster (HZ), also known as shingles. People over 50 years of age and those with weakened immune systems are more likely to develop shingles.
E N D
Herpes Zoster (Shingles) MarketMarket size, Industry outlook, Market Forecast, Demand Analysis, Market Share, Market Report 2022-2027 Contact: Venkat Reddy sales@industryarc.com (+1) 970-236-3677
DownloadPDF Brochure • Herpes Zoster (Shingles) Market Size is estimated to reach $275.9 million by 2027 and is poised to grow at a CAGR of 3.5% over the forecast period of 2022-2027. • The varicella-zoster virus, which is a common viral infection of the nerves, causes herpes zoster (HZ), also known as shingles. People over 50 years of age and those with weakened immune systems are more likely to develop shingles. Contact: (+1)970-236-3677 InquiryBefore Buying Email:sales@industryarc.com
DownloadPDF Brochure • Key Takeaways • Geographically, North America held a dominant market share in the year 2021 owing to the better diagnostic techniques in this region. In addition, various treatments available to cure such infections are further surging the growth of the Herpes Zoster (Shingles) Market Size. • The Herpes Zoster (Shingles) Market is projected to grow owing to the increase in consumption of immunosuppressant drugs and the growing prevalence of postherpetic neuralgia. • A detailed analysis of strengths, weaknesses, opportunities and threats will be provided in the Herpes Zoster (Shingles) Market Report. Contact: (+1)970-236-3677 InquiryBefore Buying Email:sales@industryarc.com
DownloadPDF Brochure Herpes Zoster (Shingles) Market Segment Analysis - by Treatment Herpes Zoster (Shingles) Market based on treatment can be further segmented into Antiviral Medication, Anti-inflammatory Medication and Others. The anti-inflammatory medication segment held a dominant market share in the year 2021 owing to the growing demand for anti-inflammatory drugs like corticosteroids. The oral use of prednisone which is in a class of corticosteroids is supposed to be beneficial for treating herpes zoster infection, thus, driving the growth of the Herpes Zoster (Shingles) Market Share. Contact: (+1)970-236-3677 InquiryBefore Buying Email:sales@industryarc.com
DownloadPDF Brochure • Herpes Zoster (Shingles) Market Industry Outlook • Abbott Laboratory • Bausch Health • Cipla Inc. • Camber Pharmaceuticals. • GlaxoSmithKline plc. • Merck & Co. Contact: (+1)970-236-3677 InquiryBefore Buying Email:sales@industryarc.com
DownloadPDF Brochure Herpes Zoster (Shingles) Market - Forecast(2022 - 2027) LearnMoreAbouttheReport @ https://www.industryarc.com/Report/17392/herpes-zoster-shingles-market.html Contact: (+1)970-236-3677 InquiryBefore Buying Email:sales@industryarc.com
DownloadPDF Brochure • You Can Customize the Report as Per YourNeed. We have included Some CustomizationOptions: • CompanyProfile • AnalystBriefing • DataTables • KeyContacts • FreeCustomization • Purchase Full Report @https://www.industryarc.com/purchasereport.php?id=17392 Contact: (+1)970-236-3677 InquiryBefore Buying Email:sales@industryarc.com
DownloadPDF Brochure For More DetailsContact VenkatReddy Contact: (+1)970-236-3677 Email:sales@industryarc.com Connect with us on LinkedIn @ http://www.linkedin.com/company/industryarc Contact: (+1)970-236-3677 InquiryBefore Buying Email:sales@industryarc.com